The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A multicenter, open-label phase 2a study of ibrutinib with or without cytarabine in patients with acute myeloid leukemia (PCYC-1131).
 
Jorge E. Cortes
Consulting or Advisory Role - Ambit BioSciences; Ariad; Arog; Astellas Pharma; Celator; Novartis
Research Funding - Ambit BioSciences; Ariad; Arog; Astellas Pharma; Celator; Novartis
 
Elihu Estey
No Relationships to Disclose
 
Anthony Selwyn Stein
Honoraria - Amgen
Consulting or Advisory Role - Amgen
Speakers' Bureau - Amgen
 
Thorsten Graef
Employment - Pharmacyclics
Stock and Other Ownership Interests - Pharmacyclics
 
Nora Cavazos
Employment - Pharmacyclics
 
Taisei Kinoshita
Employment - Pharmacyclics
 
Ying Luan
Employment - Pharmacyclics
 
Ahmed Tawashi
Employment - Pharmacyclics